Shares of Valeant Pharmaceuticals International Inc (VRX.N) fell on Thursday after the campaign of Democratic presidential contender Hillary Clinton posted a blog from an Iowa event detailing exorbitant price hikes for a migraine drug made by the company.
At an Iowa town hall over the weekend, Clinton read from a letter saying that the list price for 10 vials of migraine drug D.H.E. 45 had increased to more than $14,000 in December, compared with just over $3,000 in June of 2014.
“This is predatory pricing. It is unjustified. It is wrong,” Clinton said, according to the post.